Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Weller

Showing results (241-250 of 939) with videos related to

Pageof 94
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental GliomasAlexandros Papachristodoulou, Manuela Silginer, Michael Weller, et al.
Journal of Neurochemistry|February 27, 2018
Transcriptional control of O<sup>6</sup> -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastomaCaroline Happold, Nina Stojcheva, Manuela Silginer, et al.
Neuro-Oncology|November 19, 2024
Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?Ghazaleh Tabatabai, Michael Platten, Matthias Preusser, et al.
Neuro-Oncology|July 4, 2025
Point/counterpoint: intrathecal therapy for patients with leptomeningeal metastases from solid tumorsEmilie Le Rhun, Barbara J O'Brien, Elena Pentsova, et al.
Brain : a Journal of Neurology|April 12, 2003
Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathiesHeinz Wiendl, Meike Mitsdoerffer, Dagmar Schneider, et al.
Annals of Neurology|September 4, 2003
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomasMichael Platten, Alexandra Kretz, Ulrike Naumann, et al.
Journal of Cancer Research and Clinical Oncology|August 27, 2021
Radiotherapy for glioblastoma patients with poor performance statusChristina Schröder, Dorothee Gramatzki, Erwin Vu, et al.
Journal of Neuro-Oncology|May 16, 2006
Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factorsKristoph Jahnke, Eckhard Thiel, Peter Martus, et al.
Journal of Neuro-Oncology|April 13, 2002
BCL-2 family proteins modulate radiosensitivity in human malignant glioma cellsJohannes R Streffer, Andreas Rimner, Johannes Rieger, et al.
European Neurology|November 28, 2012
Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomasKatharina Seystahl, Benedikt Wiestler, Thomas Hundsberger, et al.
Pageof 94

Showing results (241-250 of 939) with videos related to

Sort By:
Pageof 94
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2019
Therapeutic Targeting of TGFβ Ligands in Glioblastoma Using Novel Antisense Oligonucleotides Reduces the Growth of Experimental GliomasAlexandros Papachristodoulou, Manuela Silginer, Michael Weller, et al.
Journal of Neurochemistry|February 27, 2018
Transcriptional control of O<sup>6</sup> -methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastomaCaroline Happold, Nina Stojcheva, Manuela Silginer, et al.
Neuro-Oncology|November 19, 2024
Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lessons ignored?Ghazaleh Tabatabai, Michael Platten, Matthias Preusser, et al.
Neuro-Oncology|July 4, 2025
Point/counterpoint: intrathecal therapy for patients with leptomeningeal metastases from solid tumorsEmilie Le Rhun, Barbara J O'Brien, Elena Pentsova, et al.
Brain : a Journal of Neurology|April 12, 2003
Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathiesHeinz Wiendl, Meike Mitsdoerffer, Dagmar Schneider, et al.
Annals of Neurology|September 4, 2003
Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomasMichael Platten, Alexandra Kretz, Ulrike Naumann, et al.
Journal of Cancer Research and Clinical Oncology|August 27, 2021
Radiotherapy for glioblastoma patients with poor performance statusChristina Schröder, Dorothee Gramatzki, Erwin Vu, et al.
Journal of Neuro-Oncology|May 16, 2006
Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factorsKristoph Jahnke, Eckhard Thiel, Peter Martus, et al.
Journal of Neuro-Oncology|April 13, 2002
BCL-2 family proteins modulate radiosensitivity in human malignant glioma cellsJohannes R Streffer, Andreas Rimner, Johannes Rieger, et al.
European Neurology|November 28, 2012
Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomasKatharina Seystahl, Benedikt Wiestler, Thomas Hundsberger, et al.
Pageof 94